Related Experiment Videos
[Quality of life as a target variable in oncologic clinical research]
A Schmidt1, W Weidenhammer, S Groll
1Institut für Klinische Forschung Hamburg.
Zentralblatt Fur Chirurgie
|January 1, 1990
Abstract:
The change of target variables in palliative cancer treatment led to a new evaluation of quality of life. Its use as a target variable to discriminate different therapies is problematic. Investigations with a patient-questionnaire assessing quality of life showed that the validity of this term is difficult to judge. At present it should be used in clinical research as an accompanying variable only.